S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
The Greatest Bull Market in Crypto History… (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
The Greatest Bull Market in Crypto History… (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
The Greatest Bull Market in Crypto History… (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
The Greatest Bull Market in Crypto History… (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
Free Trial

Medifast (MED) Earnings Date, Estimates & Call Transcripts

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)
Free med Stock Alerts
$31.88
-0.37 (-1.15%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Apr. 29
After Market Closes
Confirmed
Actual EPS
(Feb. 20)
$1.09 Beat By $0.10
Consensus EPS
(Feb. 20)
$0.99
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medifast Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.82$1.72$1.270.250 - 0.950
Q2 20241$1.75$1.75$1.75 
Q3 20241$1.83$1.83$1.83 
Q4 20241$1.78$1.78$1.78 
FY 20245$6.18$7.08$6.63 
Q1 20251$2.04$2.04$2.04 
Q2 20251$1.94$1.94$1.94 
Q3 20251$1.93$1.93$1.93 

MED Earnings Date and Information

Medifast last released its earnings data on February 20th, 2024. The specialty retailer reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.99 by $0.10. The company earned $191.02 million during the quarter, compared to analyst estimates of $184.17 million. Its revenue for the quarter was down 43.4% on a year-over-year basis. Medifast has generated $9.11 earnings per share over the last year ($9.11 diluted earnings per share) and currently has a price-to-earnings ratio of 3.5. Earnings for Medifast are expected to grow by 40.45% in the coming year, from $3.56 to $5.00 per share. Medifast has confirmed that its next quarterly earnings report will be published on Monday, April 29th, 2024. Medifast will be holding an earnings conference call on Monday, April 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call. or dial in at 844-512-2921 with passcode "13745406".

Medifast Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/29/2024
Confirmed)		-------  
2/20/2024Q4 2023$0.99$1.09+$0.10$1.63$184.17 million$191.02 million    
11/6/2023Q3 2023$1.02$2.12+$1.10$2.12$232.10 million$235.87 million    
8/7/2023Q2 2023$1.44$2.77+$1.33$2.77$270.20 million$296.20 million    
5/1/2023Q1 2023$2.40$3.67+$1.27$3.67$319.50 million$349.00 million    
2/21/2023Q4 2022$2.18$3.70+$1.52$4.99$306.70 million$337.25 million
11/3/2022Q3 2022$1.91$3.32+$1.41$3.37-$390.40 million
8/3/2022Q2 2022$3.28$3.87+$0.59$4.32$462.60 million$453.33 million
5/2/2022Q1 2022$3.56$3.59+$0.03$3.59$415.20 million$417.60 million
2/23/2022Q4 2021$2.67$2.91+$0.24$2.91$375.79 million$377.80 million    
11/4/2021Q3 2021$2.92$3.56+$0.64$3.56$402.80 million$413.40 million    
8/4/2021Q2 2021$3.30$3.96+$0.66$3.96$359.25 million$394.20 million    
5/4/2021Q1 2021$2.72$3.46+$0.74$3.46$279.12 million$340.70 million  

Medifast Earnings - Frequently Asked Questions

When is Medifast's earnings date?

Medifast has confirmed that its next quarterly earnings data will be published on Monday, April 29th, 2024. Learn more on MED's earnings history.

Did Medifast beat their earnings estimates last quarter?

In the previous quarter, Medifast (NYSE:MED) reported $1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.99 by $0.10. Learn more on analysts' earnings estimate vs. MED's actual earnings.

How can I listen to Medifast's earnings conference call?

The conference call for Medifast's latest earnings report can be listened to online. Listen to Conference Call

How can I read Medifast's conference call transcript?

The conference call transcript for Medifast's latest earnings report can be read online. Read Transcript

How much revenue does Medifast generate each year?

Medifast (NYSE:MED) has a recorded annual revenue of $1.07 billion.

How much profit does Medifast generate each year?

Medifast (NYSE:MED) has a recorded net income of $99.42 million. MED has generated $9.11 earnings per share over the last four quarters.

What is Medifast's price-to-earnings ratio?

Medifast (NYSE:MED) has a trailing price-to-earnings ratio of 3.50 and a forward price-to-earnings ratio of 8.96.

What is Medifast's EPS forecast for next year?

Medifast's earnings are expected to grow from $3.56 per share to $5.00 per share in the next year, which is a 40.45% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:MED) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
The #1 Crypto for 2024
InvestorPlace
The Greatest Bull Market in Crypto History…
Weiss Ratings
A.I. is a Tidal Wave - Here’s What to Buy
Chaikin Analytics